BMRN Biomarin Pharmaceutical Inc. - Registered Shares

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Biomarin Pharmaceutical Inc. - Registered Shares market cap is $15.54B.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Biomarin Pharmaceutical Inc. - Registered Shares 52 week high is $99.56 as of May 09, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Biomarin Pharmaceutical Inc. - Registered Shares 52 week low is $76.02 as of May 09, 2024.

Biomarin Pharmaceutical Inc. - Registered Shares stock price today is $81.72.

Biomarin Pharmaceutical Inc. - Registered Shares stock price yesterday was $81.83.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Biomarin Pharmaceutical Inc. - Registered Shares’s P/E ratio is 76.58.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Biomarin Pharmaceutical Inc. - Registered Shares P/B ratio is 3.0607.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Biomarin Pharmaceutical Inc. - Registered Shares's EBITDA is 53.88.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Biomarin Pharmaceutical Inc. - Registered Shares 50-day moving average is $86.45.

Biomarin Pharmaceutical Inc. - Registered Shares has 3,401 employees.